<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83</article-id><article-id pub-id-type="doi">10.36691/RJA83</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Pimecrolimus in pediatrics. Clinical experience</article-title><trans-title-group xml:lang="ru"><trans-title>Пимекролимус в детской клинической практике. Опыт применения</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Revyakina</surname><given-names>V A</given-names></name><name xml:lang="ru"><surname>Ревякина</surname><given-names>В А</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научный центр здоровья детей РАМН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Revyakina</surname><given-names>V A</given-names></name><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Научный центр здоровья детей РАМН</institution></aff></aff-alternatives><aff id="aff2"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2007-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2007</year></pub-date><volume>4</volume><issue>3</issue><issue-title xml:lang="en">NO3 (2007)</issue-title><issue-title xml:lang="ru">№3 (2007)</issue-title><fpage>54</fpage><lpage>57</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2007, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2007, Фармарус Принт Медиа</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2009-09-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/83">https://rusalljournal.ru/raj/article/view/83</self-uri><abstract xml:lang="en"><p/></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>atopic dermatitis</kwd><kwd>topical therapy</kwd><kwd>children</kwd><kwd>pimecrolimus</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>атопический дерматит</kwd><kwd>наружная терапия</kwd><kwd>дети</kwd><kwd>пимекролимус</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Сергеев Ю.В. Атопический дерматит: от патогенеза к эффективной терапии. Иммунопатол., аллергол., инфектол., 2004, № 3, с. 1-8.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Сергеев Ю.В., Новиков Д.К., Караулов А.В., Сергеев А.Ю. Атопический дерматит: гетерогенность клинических форм и разнообразие механизмов патогенеза. Иммунопатол., аллергол., инфектол., 2001, №3, с. 61-73.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Гервазиева В.Б., Самойликов П.В., Сверановская В.В. Современные аспекты иммунопатогенеза атопического дерматита. Рос. Аллергол. Журн., 2006, №, с. 5-12.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Диагностика и лечение атопического дерматита у детей и взрослых. Европейская академия аллергологии и клинической иммунологии/Американская академия аллергии, астмы и иммунологии/группа PRACTALL. Рос. Аллергол. Журн., 2006 (приложение), 40 с.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Moreno J.C, Gimenez. Atopic dermatitis (revive article). Allergy Immunol. Clin., 2000, v. 15, p. 279-295.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Leung D.Y.M., Bieber T. Atopic dermatitis. Lancet, 2003, № 36, p 151-160.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Werfel T., Kapp A. What do we know about etiopathology of the intrinsic type of atopic dermatitis? Curr.Probl. Dermatol., 1999, v. 28, p 29-36.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Eichenfield L.F., Lucky A.W., Boguiewicz M. et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J. Am. Acad. Dermatol., 2002, v. 46, p. 495-504.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ho V., Halbert A., Takaoka R. et al. Pimecrolimus (Elidel SDZ AMS 98) cream 1% is effective and sate in infantscaged 3-23 months whth atopic dermatitis. J. Рediat., 2003, v. 142, p. 155-162.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Meurer M., Folster-Hoist R., Wozel G. еt al. Pimecrolimus cream 1% (Elidel) provides significant and rapid relief of pruritis and improves disease control and quality of the atopic dermatitis. J. Invest. Dermatology, 2002, v. 119, p. 350 (abstr. 855).</mixed-citation></ref></ref-list></back></article>
